PGNY
Progyny, Inc.NASDAQHealthcare$16.60-1.54%ClosedMarket Cap: $1.36B
As of 2026-04-06
Valuation
P/E (TTM)
23.23
PEG
3.02
P/B
2.74
P/S
1.05
EV/EBITDA
13.01
DCF Value
$23.13
FCF Yield
13.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
23.6%
Operating Margin
6.6%
Net Margin
4.5%
ROE
11.4%
ROA
8.2%
ROIC
9.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $318.4M | 24.1% | $15.2M | $12.5M | $0.14 | — |
| FY 2025 | $1.29B | 23.6% | $85.3M | $58.5M | $0.65 | — |
| Q3 2025 | $313.3M | 23.2% | $21.5M | $13.9M | $0.15 | — |
| Q2 2025 | $332.9M | 23.7% | $24.4M | $17.1M | $0.19 | — |
| Q1 2025 | $324.0M | 23.4% | $24.2M | $15.1M | $0.17 | — |
| Q4 2024 | $298.4M | 21.3% | $15.8M | $10.5M | $0.12 | — |
| FY 2024 | $1.17B | 21.7% | $67.5M | $54.3M | $0.57 | — |
| Q3 2024 | $286.6M | 20.7% | $12.5M | $10.4M | $0.11 | — |
| Q2 2024 | $304.1M | 22.5% | $20.7M | $16.5M | $0.17 | — |
| Q1 2024 | $278.1M | 22.4% | $18.5M | $16.9M | $0.17 | — |
| Q4 2023 | $269.9M | 21.1% | $13.8M | $13.5M | $0.13 | — |
| FY 2023 | $1.09B | 21.9% | $62.2M | $62.0M | $0.62 | — |